Mesa Laboratories, Inc. filed a Form 8-K on September 8, 2026, reporting the certified voting results from its annual meeting of shareholders held that same day, covering director elections, auditor ratification, and an advisory vote on executive compensation.

Key Highlights

  • Shares represented: 4,872,692 of 5,595,869 shares entitled to vote were present in person or by proxy at the annual meeting.
  • All seven directors elected: John Sullivan, Siddhartha Kadia, Shiraz Ladiwala, Jenny Alltoft, Mark Capone, Shannon Hall, and R. Tony Tripeny were each elected to one-year terms ending at the 2027 annual meeting.
  • Auditor ratified: Baker Tilly US, LLP was approved as independent registered public accounting firm for the fiscal year ending March 31, 2027, receiving 4,814,383 votes in favor and 56,778 against.
  • Executive pay advisory vote: Named executive officer compensation was approved on a non-binding basis, with 4,317,389 votes for, 136,782 against, and 80,326 abstentions.
  • Broker non-votes: 338,195 broker non-votes were recorded for each of the director election and the executive compensation proposals.

Mesa Laboratories 2026 Annual Meeting: Director, Auditor, and Pay Votes Certified

According to the filing, Mesa Laboratories (NASDAQ:MLAB) held its 2026 annual meeting of shareholders on September 8, 2026. Of the 5,595,869 shares entitled to vote, 4,872,692 were represented in person or by proxy. The company disclosed certified results for three proposals under Item 5.07 of the Form 8-K.

On Proposal 1, all seven director nominees were elected to serve one-year terms until the 2027 annual meeting. The highest vote total among directors went to Siddhartha Kadia, Ph.D., with 4,421,045 votes in favor and 113,452 withheld. R. Tony Tripeny received the fewest "for" votes among the seven, with 4,352,734 in favor and 181,763 withheld. Each director nominee also had 338,195 broker non-votes recorded against their candidacy.

On Proposal 2, the filing reported that Baker Tilly US, LLP's appointment as independent auditor for the fiscal year ending March 31, 2027 was approved, with 4,814,383 votes for, 56,778 against, and 1,531 abstentions. No broker non-votes were recorded for this proposal, as the filing shows a dash in that column. On Proposal 3, the non-binding advisory vote on named executive officer compensation passed with 4,317,389 votes for, 136,782 against, and 80,326 abstentions, alongside 338,195 broker non-votes. The filing was signed by John Sakys, Chief Financial Officer, on September 8, 2026.

What Was Disclosed

Mesa Laboratories disclosed certified shareholder vote results from its September 8, 2026 annual meeting, covering the election of seven directors to one-year terms, ratification of Baker Tilly US, LLP as auditor, and a non-binding advisory approval of named executive officer compensation.